Search

Author/Creator Wood, Andrew C.

1. Initial testing (Stage 1) of the antibody‐maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program. Issue 11 (24th June 2013)

Authors:
Wood, Andrew C.; Maris, John M.; Gorlick, Richard; Kolb, E. Anders; Keir, Stephen T.; Reynolds, C. Patrick; Kang, Min H.; Wu, Jianrong; Kurmasheva, Raushan T.; Whiteman, Kathleen; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 60:Issue 11(2013:Nov.)
Page Start:
1860
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group. Issue 12 (1st October 2021)

Authors:
Elgarten, Caitlin W.; Wood, Andrew C.; Li, Yimei; Alonzo, Todd A.; Brodersen, Lisa Eidenschink; Gerbing, Robert B.; Getz, Kelly D.; Huang, Y‐S Vera; Loken, Michael; Meshinchi, Soheil; Pollard, Jessica A.; Sung, Lillian; Woods, William G.; Kolb, E. Anders; Gamis, Alan S.; Aplenc, Richard
Journal:
Pediatric blood & cancer
Issue:
Volume 68:Issue 12(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗